# Hemodynamic Effects of Terlipressin and High Dose Octreotide

> **NCT02119884** · PHASE4 · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 88 (actual)

## Conditions studied

- Gastric and Esophageal Varices

## Interventions

- **DRUG:** Terlipressin
- **DRUG:** Octreotide

## Key facts

- **NCT ID:** NCT02119884
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2016-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02119884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02119884, "Hemodynamic Effects of Terlipressin and High Dose Octreotide". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02119884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*